The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Fat Accumulation in the Liver Is Associated with Defects in Insulin Suppression of Glucose Production and Serum Free Fatty Acids Independent of Obesity in Normal Men
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Even small amounts of weight loss induced by a negative energy balance affects many variables pertaining to body-fat composition and lipid metabolism -variables that probably contribute to the metabolic abnormalities associated with obesity.[22][23][24][25]”
From Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease (2004) · cites this paper as [24]
In the citing paper
“Even small amounts of weight loss induced by a negative energy balance affects many variables pertaining to body-fat composition and lipid metabolism -variables that probably contribute to the metabolic abnormalities associated with obesity.[22][23][24][25]”
From Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease (2004) · cites this paper as [24]
In the citing paper
“Several studies have shown a strong relationship among nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes mellitus.1–3”
From Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease (2010) · cites this paper as [2]
In the citing paper
“There is now strong evidence that nonalcoholic fatty liver disease has an important role in causing hepatic insulin resistance.1–3,23–27”
From Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease (2010) · cites this paper as [2]
In the citing paper
“There is increasing evidence for a causal relationship between hepatic steatosis and hepatic insulin resistance both in rodent models with hepatic steatosis and in patients with nonalcoholic fatty liver disease (4, 18-25).”
From Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men (2006) · cites this paper as [20]
In the citing paper
“Fatty acid-induced reductions in insulin receptor number and function in the liver (211) may also reduce hepatic insulin clearance (226), causing systemic hyperinsulinemia, itself a contributor to both insulin resistance and reduced mitochondrial function (214,227,228).”
From The role of mitochondria in the pathogenesis of type 2 diabetes (2010) · cites this paper as [226]
In the citing paper
“The associations between liver fat and hepatic insulin resistance have previously been reported by Bajaj et al, 62 who studied 14 type 2 diabetic patients, and by us in nondiabetic subjects 24,39 and type 2 diabetic patients treated with insulin. 36,38”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [39]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 301–400 of 1,023
Trouwborst, I., Gijbels, A., Jardon, K. M. C., Siebelink, E., Hul, G. B. J., Wanders, L., Erdõs, B., Péter, S., Singh‐Povel, C. M., den Bosch, J. D. V., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.12.002 · Cited by 90
Effects of physical activity upon the liver
Shephard, R. J., & Johnson, N. A. (2014) · European Journal of Applied Physiology · doi:10.1007/s00421-014-3031-6 · Cited by 93
Pietiläinen, K. H., Rissanen, A., Kaprio, J. A., Mäkimattila, S., Häkkinen, A., Westerbacka, J., Sutinen, J., Vehkavaara, S., & Yki‐Järvinen, H. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00381.2004 · Cited by 90
Self-citationImpact of non‐alcoholic fatty pancreas disease on glucose metabolism
Yu, T., & Wang, C. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12665 · Cited by 89
Kim, S. P., Catalano, K. J., Hsu, I. R., Chiu, J. D., Richey, J. M., & Bergman, R. N. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00669.2006 · Cited by 89
Evaluation of Beneficial Metabolic Effects of Berries in High-Fat Fed C57BL/6J Mice
Heyman‐Lindén, L., Axling, U., Blanco, N., Sterner, O., Holm, C., & Berger, K. (2014) · Journal of Nutrition and Metabolism · doi:10.1155/2014/403041 · Cited by 88
Tiikkainen, M., Bergholm, R., Rissanen, A., Aro, A., Salminen, I., Tamminen, M., Teramo, K., & Yki‐Järvinen, H. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.1.22 · Cited by 88
Self-citationStanhope, K. L., Goran, M. I., Bosy‐Westphal, A., King, J. C., Schmidt, L. A., Schwarz, J., Stice, E. M., Sylvetsky, A. C., Turnbaugh, P. J., Bray, G. A., et al. (2018) · Obesity Reviews · doi:10.1111/obr.12699 · Cited by 90
Cernkovich, E. R., Deng, J., Bond, M. C., Combs, T. P., & Harp, J. B. (2008) · Endocrinology · doi:10.1210/en.2007-1148 · Cited by 87
Sphingolipid metabolism in non-alcoholic fatty liver diseases
Régnier, M., Polizzi, A., Guillou, H., & Loiseau, N. (2018) · Biochimie · doi:10.1016/j.biochi.2018.07.021 · Cited by 88
Catalano, K. J., Stefanovski, D., & Bergman, R. N. (2010) · Diabetes · doi:10.2337/db08-0675 · Cited by 84
Nuclear bile acid receptor FXR as pharmacological target: Are we there yet?
Modica, S., & Moschetta, A. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.07.082 · Cited by 83
Should Nonalcoholic Fatty Liver Disease Be Renamed?
Loria, P., Lonardo, A., & Carulli, N. (2005) · Digestive Diseases · doi:10.1159/000084728 · Cited by 83
Williams, K. J., & Wu, X. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.004 · Cited by 83
Type 2 diabetes and remission: practical management guided by pathophysiology
Taylor, R. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13214 · Cited by 90
Perseghin, G., Lattuada, G., COBELLI, F. D., Esposito, A., Costantino, F., Canu, T., Scifo, P., Taddeo, F. D., Maffi, P., Secchi, A., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-0014-5 · Cited by 82
Interaction of volatile organic compounds and underlying liver disease: a new paradigm for risk
Lang, A. L., & Beier, J. I. (2018) · Biological Chemistry · doi:10.1515/hsz-2017-0324 · Cited by 79
Understanding the cause of type 2 diabetes
Taylor, R. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00157-8 · Cited by 88
Westerbacka, J., Kotronen, A., Fielding, B. A., Wahren, J., Hodson, L., Perttilä, J., Seppänen‐Laakso, T., Suortti, T., Arola, J. T., Hultcrantz, R. W., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.064 · Cited by 79
Self-citationTime course of liver lipid infiltration in ovariectomized rats: Impact of a high-fat diet
Paquette, A., Shinoda, M., RABASA-LHORET, R. P. R., Prud’homme, D., & Lavoie, J.-M. (2007) · Maturitas · doi:10.1016/j.maturitas.2007.08.002 · Cited by 78
Hao, J., Chen, C., Huang, K., Huang, J., Li, J., Liu, P., & Huang, H. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.09.047 · Cited by 77
Kotronen, A., Yki‐Järvinen, H., Aminoff, A., Bergholm, R., Pietiläinen, K. H., Westerbacka, J., Talmud, P. J., Humphries, S. E., Hamsten, A., Isomaa, B., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0900 · Cited by 77
Self-citationPostprandial Lipemia Associates with Liver Fat Content
Matikainen, N., Mänttäri, S., Westerbacka, J., Vehkavaara, S., Lundbom, N. M. I., Yki‐Järvinen, H., & Taskinen, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0187 · Cited by 76
Self-citationGauthier, M.-S., Couturier, K., Charbonneau, A., & Lavoie, J.-M. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802628 · Cited by 76
Balasubramanian, R., Gerrard, J., Man, C. D., Firbank, M., Lane, A. P., English, P. T., Cobelli, C., & Taylor, R. (2008) · Diabetes · doi:10.2337/db07-1828 · Cited by 76
Non‐alcoholic fatty liver disease is associated with cardiovascular disease risk markers
Edens, M. A., Kuipers, F., & Stolk, R. P. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00594.x · Cited by 77
Comorbidities and Metabolic Derangement of NAFLD
Bang, K. B., & Cho, Y. K. (2015) · Journal of Lifestyle Medicine · doi:10.15280/jlm.2015.5.1.7 · Cited by 76
Ruddock, M. W., Stein, A., Landaker, E., Park, J., Cooksey, R. C., McClain, D., & Patti, M.-E. (2008) · Journal of Biochemistry · doi:10.1093/jb/mvn105 · Cited by 75
Examining the safety of PPAR agonists – current trends and future prospects
Bortolini, M., Wright, M. B., Bopst, M., & Balas, B. I. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.741585 · Cited by 76
Schindhelm, R. K., Dekker, J. M., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., Heine, R. J., & Diamant, M. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02100.x · Cited by 75
Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease
Yoon, H. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i11.800 · Cited by 75
Quantification of Liver Glucose Metabolism by Positron Emission Tomography: Validation Study in Pigs
Iozzo, P., Järvisalo, M. J., Kišš, J., Borra, R., Naum, G. A., Viljanen, A. P. M., Viljanen, T., Gastaldelli, A., Buzzigoli, E., Guiducci, L., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.12.040 · Cited by 75
Chang, Y., Ryu, S., Sung, E., Woo, H.-Y., Cho, S.-I., Yoo, S.-H., Ahn, H.-Y., & Choi, N.-K. (2009) · Gut · doi:10.1136/gut.2008.161885 · Cited by 75
Angiotensin 1-7 as Means to Prevent the Metabolic Syndrome
Marcus, Y., Shefer, G., Sasson, K., Kohen, F., Limor, R., Pappo, O., Nevo, N., Biton, I. E., Bach, M. Y., Berkutzki, T., et al. (2012) · Diabetes · doi:10.2337/db12-0792 · Cited by 75
Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat Diet
Xia, S., Le, G., Wang, P., Qiu, Y., Jiang, Y., & Xue Ming, T. A. N. G. (2016) · Nutrients · doi:10.3390/nu8120799 · Cited by 76
Tripathy, D., Eriksson, K. F., Orho-Melander, M., Fredriksson, J., Ahlqvist, G., & Groop, L. (2004) · Diabetologia · doi:10.1007/s00125-004-1393-8 · Cited by 74
Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging
Mashhood, A., Railkar, R. A., Yokoo, T., Levin, Y. S., Clark, L., Fox‐Bosetti, S., Middleton, M. S., Riek, J. K., Kauh, E. A., Dardzinski, B. J., et al. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23928 · Cited by 74
Gong, H., Tan, H., Fang, N., Song, T., Li, S., Zhong, M., Zhang, W., & Zhang, Y. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.10.018 · Cited by 72
Shi, S. Y., García-Martín, R., Duncan, R. E., Choi, D., Lu, S.-Y., Schroer, S. A., Cai, E. P., Luk, C. T., Hopperton, K. E., Domenichiello, A. F., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.317453 · Cited by 72
Taylor, R., Barnes, A. C., Hollingsworth, K. G., Irvine, K. M., Solovyova, A. S., Clark, L., Kelly, T., Martin-Ruiz, C., Romeres, D., Koulman, A., et al. (2023) · Clinical Science · doi:10.1042/cs20230586 · Cited by 71
The Causal Role of Ectopic Fat Deposition in the Pathogenesis of Metabolic Syndrome
Janssen, J. A. M. J. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413238 · Cited by 75
Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: a review
Fischbach, F., & Bruhn, H. (2008) · Liver International · doi:10.1111/j.1478-3231.2007.01647.x · Cited by 71
Zadjali, F., Santana‐Farré, R., Vesterlund, M., Carow, B., de Mirecki-Garrido, M., Hernández, I., Flodström‐Tullberg, M., Parini, P., Rottenberg, M. E., Norstedt, G., et al. (2012) · The FASEB Journal · doi:10.1096/fj.12-205583 · Cited by 74
Thiazolidinediones ? some recent developments
Stümvoll, M. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.7.1179 · Cited by 71
Yki‐Järvinen, H., Sutinen, J., Silveira, A. M. V., Korsheninnikova, E., Fisher, R. M., Kannisto, K., Ehrenborg, E., Eriksson, P. O., & Hamsten, A. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000062885.61917.a5 · Cited by 71
Self-citationImpaired renal function in morbid obese patients with nonalcoholic fatty liver disease
Machado, M. V., Gonçalves, S., Carepa, F., Coutinho, J., Costa, A., & Cortez‐Pinto, H. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02623.x · Cited by 71
Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo
Fishman, S., Muzumdar, R. H., Atzmon, G., Ma, X., Yang, X., Einstein, F. H., & Barzilai, N. (2006) · The FASEB Journal · doi:10.1096/fj.06-6557com · Cited by 70
Intrahepatic Lipids Are Predicted by Visceral Adipose Tissue Mass in Healthy Subjects
Thamer, C., Machann, J., Haap, M. M., Stefan, N., Heller, E., Schnödt, B., Stümvoll, M., Claussen, C. D., Fritsche, A., Schick, F., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2726 · Cited by 70
Ikegami, T., Hyogo, H., Honda, A., Miyazaki, T., Tokushige, K., Hashimoto, E., Inui, K., Matsuzaki, Y., & Tazuma, S. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0585-0 · Cited by 70
Trunk Fat Is Associated With Increased Serum Levels of Alanine Aminotransferase in the United States
Ruhl, C. E., & Everhart, J. E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.053 · Cited by 69
Advances in the Understanding and Treatment of Nonalcoholic Fatty Liver Disease
Harrison, S. A., & Bisceglie, A. M. D. (2003) · Drugs · doi:10.2165/00003495-200363220-00001 · Cited by 69
Krssak, M., & Roden, M. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000021434.98627.dc · Cited by 68
Measures of insulin sensitivity.
Bloomgarden, Z. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.06.007 · Cited by 65
Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia
Visser, M. E., Lammers, N. M., Nederveen, A. J., van der Graaf, M., Heerschap, A., Ackermans, M. T., Sauerwein, H. P., Stroes, E. S. G., & Serlie, M. J. M. (2011) · Diabetologia · doi:10.1007/s00125-011-2157-x · Cited by 71
Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes
Käräjämäki, A. J., Bloigu, R., Kauma, H., Kesäniemi, Y. A., Koivurova, O., Perkiömäki, J. S., Huikuri, H. V., & Ukkola, O. H. (2016) · Metabolism · doi:10.1016/j.metabol.2016.06.009 · Cited by 68
UFRGS-UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL
Saúde, B. D., & Pós-Graduação, P. R. D. (2009) · Cited by 68
Obesity and diabetes: lipids, ‘nowhere to run to'
Hill, M. J., Metcalfe, D., & McTernan, P. G. (2008) · Clinical Science · doi:10.1042/cs20080050 · Cited by 69
Impact of liver diseases on the development of type 2 diabetes mellitus
Hsieh, P. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i48.5240 · Cited by 69
CD36 is important for adipocyte recruitment and affects lipolysis
Vroegrijk, I. O. C. M., van Klinken, J. B., van Diepen, J. A., van den Berg, S. A. A., Febbraio, M., Steinbusch, L. K. M., Glatz, J. F. C., Havekes, L. M., Voshol, P. J., Rensen, P. C. N., et al. (2013) · Obesity · doi:10.1002/oby.20354 · Cited by 74
Grefhorst, A., Hoekstra, J., Derks, T. G. J., Ouwens, D. M., Baller, J. F. W., Havinga, R., Havekes, L. M., Romijn, J. A., & Kuipers, F. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00063.2005 · Cited by 68
Fitness level and body composition indices: cross-sectional study among Malaysian adolescent
Hanifah, R. A., Majid, H. A., Jalaludin, M. Y., Al-Sadat, N., Murray, L., Cantwell, M. M., Su, T. T., & Nahar, A. M. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-s3-s5 · Cited by 66
Fraser, A., Ebrahim, S. B. J., Smith, G. D., & Lawlor, D. A. (2007) · Hepatology · doi:10.1002/hep.21667 · Cited by 66
Kotronen, A., Yki‐Järvinen, H., Sevastianova, K., Bergholm, R., Hakkarainen, A., Pietiläinen, K. H., Juurinen, L., Lundbom, N. M. I., & Sørensen, T. I. A. (2010) · Obesity · doi:10.1038/oby.2010.137 · Cited by 65
Self-citationUnderstanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease
Başaranoğlu, M. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i18.2223 · Cited by 65
Chazenbalk, G. D., Trivax, B., Yıldız, B. O., Bertolotto, C., Mathur, R., Heneidi, S. G., & Azziz, R. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1158 · Cited by 66
Misra, A., Shajith Anoop, S., Gulati, S., Kalaivani, M., Bhatt, S. P., & Pandey, R. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140447 · Cited by 65
Simental‐Mendía, L. E., Simental-Mendía, E., Rodríguez-Hernández, H., Rodríguez‐Morán, M., & Guerrero‐Romero, F. (2016) · PubMed · doi:10.5604/16652681.1212431 · Cited by 64
Lee, S.-Y., Lee, H., Song, J.-H., Kim, G., Jeon, S., Song, Y.-J., Lee, J., Hur, J. H., Oh, H. H., Park, S., et al. (2017) · Diabetes · doi:10.2337/db16-1232 · Cited by 62
Hockings, P. D., Changani, K. K., Saeed, N., Reid, D. G., Birmingham, J. M., O'Brien, P. J., Osborne, J. A., Toseland, C. D. N., & Buckingham, R. E. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00268.x · Cited by 63
Wendel, A. A., Li, L. O., Li, Y., Cline, G. W., Shulman, G. I., & Coleman, R. A. (2010) · Diabetes · doi:10.2337/db09-1380 · Cited by 63
Hwang, B., Jeoung, N. H., & Harris, R. A. (2009) · Biochemical Journal · doi:10.1042/bj20090390 · Cited by 61
Validity of a new automated software program for visceral adipose tissue estimation
Demerath, E. W., Ritter, K. J., Couch, W. P., Rogers, N. L., Moreno, G. J., Choh, A. C., Lee, M., Remsberg, K. E., Czerwiński, S., Chumlea, W. C., et al. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803409 · Cited by 63
Hodson, L., Bhatia, L. S., Scorletti, E., Smith, D. E., Jackson, N. C., Shojaee‐Moradie, F., Umpleby, A. M., Calder, P. C., & Byrne, C. D. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.9 · Cited by 63
MECHANISMS IN ENDOCRINOLOGY: Pathogenesis of type 2 diabetes in South Asians
Bakker, L. E. H., Sleddering, M. A., Schoones, J. W., Meinders, A. E., & Jazet, I. M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0307 · Cited by 63
Association of ALT and the metabolic syndrome among Mexican children
Elizondo‐Montemayor, L., Ugalde‐Casas, P. A., Lam-Franco, L., Bustamante-Careaga, H., Gonzalez, M. S., Gutiérrez, N. G., & Martínez, U. (2012) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2012.08.191 · Cited by 62
Smith, S. (2003) · Biochimie · doi:10.1016/j.biochi.2003.10.010 · Cited by 62
Wang, O., Cheng, Q., Liu, J., Wang, Y., Zhao, L., Zhou, F. L., & Ji, B. (2014) · Food & Function · doi:10.1039/c4fo00550c · Cited by 62
Stenholm, S., Koster, A., Alley, D. E., Visser, M., Maggio, M. G., Harris, T. B., Egan, J. M., Bandinelli, S., Guralnik, J. M., & Ferrucci, L. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03742.x · Cited by 65
Sung, K., Ryan, M. C., Kim, B. S., Cho, Y. K., Kim, B. I., & Reaven, G. M. (2007) · Diabetes Care · doi:10.2337/dc07-0512 · Cited by 60
Sevastianova, K., Sutinen, J., Kannisto, K., Hamsten, A., Ristola, M. A., & Yki‐Järvinen, H. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90224.2008 · Cited by 61
Self-citationHyysalo, J., Gopalacharyulu, P. V., Bian, H., Hyötyläinen, T., Leivonen, M., Jaser, N., Juuti, A., Honka, M., Nuutila, P., Olkkonen, V. M., et al. (2013) · Diabetes · doi:10.2337/db13-0774 · Cited by 63
Self-citationLê, K.-A., & Bortolotti, M. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328302f3ec · Cited by 60
Tsochatzis, E. A., Manolakopoulos, S., Papatheodoridis, G., & Archimandritis, A. J. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802273058 · Cited by 60
Adipokines and Redox Signaling: Impact on Fatty Liver Disease
Parola, M., & Marra, F. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3848 · Cited by 60
Kulozik, P., Jones, A., Mattijssen, F., Rose, A. J., Reimann, A., Strzoda, D., Kleinsorg, S., Raupp, C., Kleinschmidt, J. A., Müller‐Decker, K., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.011 · Cited by 61
Cordeiro, A., Costa, R., Andrade, N., Silva, C., Canabrava, N., Pena, M. J., Rodrigues, I., Andrade, S., & Ramalho, A. (2020) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2019.10.001 · Cited by 62
Brouwers, B., Schrauwen-Hinderling, V. B., Jelenik, T., Gemmink, A., Havekes, B., Bruls, Y., Dahlmans, D., Roden, M., Hesselink, M. K. C., & Schrauwen, P. (2017) · Clinical Science · doi:10.1042/cs20170261 · Cited by 59
Dervaux, N., Wubuli, M., Mégnien, J. L., Chironi, G. N., & Simon, A. C. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.11.032 · Cited by 59
Strong and persistent effect on liver fat with a Paleolithic diet during a two-year intervention
Otten, J., Mellberg, C., Ryberg, M., Sandberg, S., Kullberg, J., Lindahl, B., Larsson, C. L., Hauksson, J. B., & Olsson, T. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.4 · Cited by 60
Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis.
Başaranoğlu, M., & Neuschwander‐Tetri, B. A. (2006) · PubMed Central · Cited by 58
Kwak, M., Kim, D., Chung, G. E., Kim, W. K., Kim, Y. J., & Yoon, J. (2014) · Liver International · doi:10.1111/liv.12552 · Cited by 59
The Role of Non-Alcoholic Fatty Liver Disease in Cardiovascular Disease
Perseghin, G. (2010) · Digestive Diseases · doi:10.1159/000282088 · Cited by 57
Shaharyar, S., Roberson, L. L., Jamal, O. S., Younus, A., Blaha, M. J., Ali, S. S., Zide, K., Agatston, A. A., Blumenthal, R. S., Conceição, R., et al. (2015) · Journal of Obesity · doi:10.1155/2015/178526 · Cited by 57
Graff, M., North, K. E., Franceschini, N., Reiner, A. P., Feitosa, M. F., Carr, J. J., Gordon‐Larsen, P., Wojczynski, M. K., & Borecki, I. B. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.65 · Cited by 57
Non‐alcoholic fatty liver disease
Tuyama, A. C., & Chang, C. (2012) · Journal of Diabetes · doi:10.1111/j.1753-0407.2012.00204.x · Cited by 58
High Protein Diet and Metabolic Plasticity in Non-Alcoholic Fatty Liver Disease: Myths and Truths
Chiara, F. D., Checcllo, C. U., & Ramón‐Azcón, J. (2019) · Nutrients · doi:10.3390/nu11122985 · Cited by 58
PASSCLAIM1?Body weight regulation, insulin sensitivity and diabetes risk
Riccardi, G., Aggett, P. J., Brighenti, F., Delzenne, N. M., Frayn, K. N., Nieuwenhuizen, A. G., Pannemans, D. L. E., Theis, S., Tuijtelaars, S., & Vessby, B. O. (2004) · European Journal of Nutrition · doi:10.1007/s00394-004-1202-7 · Cited by 60
Jung, I., Koo, D.-J., & Lee, W. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0350 · Cited by 61
Shah, P., Mudaliar, S. R. D., Chang, A. R., Aroda, V. R., André, M., Burke, P., & Henry, R. R. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01370.x · Cited by 55
Priego, T., Sánchez, J., Palou, A., & Picó, C. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.18 · Cited by 56
Metadata
- Authors
- Seppala-Lindroos, A.
- Corresponding author
- Seppala-Lindroos, A.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-07-01
- Volume
- 87
- Issue
- 7
- Pages
- 3023-3028
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W4237246788
- Cited by
- 168
- References
- 0
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 2 · 2022: 3 · 2020: 2 · 2018: 2 · 2016: 7 · 2015: 3 · 2014: 7 · 2013: 13 · 2012: 23
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- hepatic lipid accumulation, insulin suppression, glucose production, serum free fatty acids, obesity, insulin resistance, hepatic glucose metabolism, non-obese men
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
